| Product ID |
Product Name |
CAS# |
Purity |
| Y3308402 |
Biotin-PEG5-CH2CH2COOH |
2252330-85-9 |
95%+ |
| Y1338170 |
4-[2-(2-Aminoethoxy)ethoxy]butanoic acid tert-butyl ester |
875459-35-1 |
97% |
| Y3317333 |
tert-Butyl 2-[3-[4-(3-hydroxypropoxy)butoxy]propoxy]acetate |
2052306-04-2 |
97% |
| Y3311111 |
Br-PEG6-CH2COOH |
411241-11-7 |
97% |
| Y3290575 |
Isonardoperoxide |
205248-65-3 |
98.0% |
| Y3309591 |
N-(1-benzyl-4-piperidyl)adamantane-1-carboxamide |
314030-54-1 |
99% |
| Y3236657 |
(4S)-3-Methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-D-prolinamide HCl |
2230826-33-0 |
97% |
| Y1237111 |
BLM-IN-1 |
2056014-40-3 |
99% |
| Y1337432 |
N-Fmoc-N-(3-buten-1-yl)-L-leucine |
1188391-88-9 |
97% |
| Y1237113 |
Ertugliflozin |
1210344-83-4 |
97% |
| Y1237174 |
DLK-IN-1 |
1620574-24-4 |
99% |
| Y3318450 |
6-Deoxyisojacareubin |
26486-92-0 |
95% |
| Y3312979 |
Masupirdine free base |
701205-60-9 |
98% |
| Y3314137 |
5-Hydroxysophoranone |
90686-12-7 |
90.0% |
| Y1241644 |
BI-167107 |
1202235-68-4 |
99% |
| Y1237205 |
REV7/REV3L-IN-1 |
1979192-13-6 |
99% |
| Y1246031 |
(1S,2S,3R)-DT-061 |
1809427-20-0 |
99% |
| Y1241690 |
Cav 2.2 blocker 1 |
1567335-29-8 |
99% |
| Y1241670 |
(Rac)-NMDAR antagonist 1 |
2435557-99-4 |
98% |
| Y1241646 |
GCN2-IN-6 |
2183470-09-7 |
99% |
| Y3317526 |
19alpha-Hydroxyfern-7-ene |
70588-12-4 |
96.5% |
| Y3318147 |
N-Cyclopropyl-3-pyrrolidinecarboxamide HCl |
960391-33-7 |
97% |
| Y3311712 |
3-Phenyl-N-[1-(phenylmethyl)-4-piperidinyl]-tricyclo[3.3.1.13,7]decane-1-carboxamide |
1252187-41-9 |
98% |
| Y3104553 |
N-Fmoc-N-allyl-L-phenylalanine |
1054548-99-0 |
97% |
| Y3104554 |
N-Fmoc-3-chloro-D-alanine |
1403834-71-8 |
97% |
| Y1241559 |
Vorolanib |
1013920-15-4 |
99% |
| Y3250531 |
N-Fmoc-N-cyclobutyl-glycine |
2138239-36-6 |
97% |
| Y3313433 |
Longiferone B |
1639810-67-5 |
93.0% |
| Y3313396 |
N-Biotinyl-5-aminopentanoic acid |
443770-03-4 |
97% |
| Y1241560 |
BPH-715 |
1059677-23-4 |
98% |
| Y3316432 |
3-[(4-Trifluoromethyl-phenoxy)methyl]piperidine HCl |
1220037-57-9 |
97% |
| Y1332482 |
N-Fmoc-2-methyl-L-glutamic acid 5-tert-butyl ester |
1072845-48-7 |
95% |
| Y1241647 |
FAUC 346 |
474432-65-0 |
99% |
| Y3263786 |
Atabecestat |
1200493-78-2 |
99% |
| Y3308035 |
6-Azido-D-norleucine HCl |
2098497-01-7 |
97% |
| Y3264665 |
LYPLAL1-IN-1 |
1966129-74-7 |
99% |
| Y1241578 |
M77976 |
394237-61-7 |
99% |
| Y3265350 |
N-(3-Methoxybenzyl)Palmitamide |
847361-96-0 |
99% |
| Y3315339 |
4'-O-Methylnyasol |
79004-25-4 |
98.0% |
| Y3297853 |
HBT1 |
489408-02-8 |
98% |
| Y1241579 |
Kinase inhibitor-1 |
2135696-72-7 |
96% |
| Y3311719 |
2-Naphthalenecarboxamide, N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]- |
192384-87-5 |
99% |
| Y3297893 |
LY3020371 hydrochloride |
1377615-44-5 |
99% |
| Y1245863 |
H4R antagonist 1 |
1429375-54-1 |
98% |
| Y3253377 |
JTE-952 |
1255303-54-8 |
99% |
| Y3297538 |
3-Chloro-4-methyl-DL-phenylalanine |
1259983-29-3 |
97% |
| Y3317534 |
Taxuspine X |
194782-02-0 |
95% |
| Y3253651 |
Toreforant |
952494-46-1 |
99% |
| Y3315347 |
N-Fmoc-O,3-dimethyl-D-tyrosine |
1998624-11-5 |
97%,ee98% |
| Y3312398 |
N-Fmoc-O-methyl-3-chloro-L-tyrosine |
2002503-89-9 |
97%,ee98% |
| Y3250369 |
(S)-2-(Cbz-amino)-4-cyclohexylbutanoic acid |
1226679-81-7 |
97% |
| Y3313674 |
6,4'-Dihydroxy-7-methoxyflavanone |
189689-32-5 |
98.0% |
| Y3244064 |
N-Fmoc-4-ethynyl-D-phenylalanine |
2349583-54-4 |
97%,ee98% |
| Y3254091 |
CA inhibitor 1 |
2189684-45-3 |
99% |
| Y3317145 |
Chlojaponilactone B |
1449382-91-5 |
98.0% |
| Y3297941 |
AKT-IN-3 |
2374740-21-1 |
99% |
| Y3309704 |
MBM-55S |
2083624-07-9 |
98% |
| Y1241423 |
PF-00356231 hydrochloride |
820223-77-6 |
99% |
| Y1250216 |
PI3Kd-IN-1 |
1911564-39-0 |
99% |
| Y3288559 |
2alpha,19alpha-Dihydroxy-3-oxo-urs-12-en-28-oic acid |
176983-21-4 |
95% |
| Y1343690 |
Copanlisib dihydrochloride |
1402152-13-9 |
99% |
| Y1236940 |
Reverse transcriptase-IN-1 |
2380001-43-2 |
98% |
| Y3296011 |
Undulatoside A |
58108-99-9 |
97.5% |
| Y3306077 |
MBM-55 |
2083622-09-5 |
99% |
| Y3318175 |
2-(2,4-Dihydroxyphenyl)-6-hydroxybenzofuran |
67736-22-5 |
95% |
| Y3317185 |
MIV-247 |
1352817-76-5 |
100% |
| Y1241453 |
CK1-IN-1 |
1784751-20-7 |
98% |
| Y3307819 |
CHMFL-ABL-121 |
2270879-07-5 |
99% |
| Y1245864 |
Jaspamycin |
22242-96-2 |
98% |
| Y3295805 |
UC-514321 |
299420-83-0 |
98% |
| Y3291234 |
Trk-IN-4 |
1799788-94-5 |
99% |
| Y1237001 |
DK419 |
2102672-22-8 |
99% |
| Y1254620 |
SRI 31215 |
1832686-44-8 |
98% |
| Y3308333 |
NAE-IN-M22 |
864420-54-2 |
98% |
| Y3297249 |
Capmatinib 2HCl.H2O |
1865733-40-9 |
99% |
| Y3291968 |
CHMFL-EGFR-202 |
2089381-40-6 |
99% |
| Y3296441 |
Epertinib hydrochloride |
2071195-74-7 |
98% |
| Y3223021 |
JHU395 |
2079938-92-2 |
99% |
| Y1343745 |
Conteltinib |
1384860-29-0 |
99% |
| Y3290456 |
Mal-PEG4-VA-PBD |
1342820-68-1 |
86% |
| Y1254621 |
RU-302 |
1182129-77-6 |
98% |
| Y3288634 |
PF-06737007 |
1863905-38-7 |
99% |
| Y3292656 |
MC-Val-Cit-PAB-clindamycin |
1639793-13-7 |
99% |
| Y3184544 |
Mal-C6-a-Amanitin |
1578249-76-9 |
98% |
| Y3191858 |
WS-383 |
2247544-02-9 |
99% |
| Y3295382 |
Mal-amido-(CH2COOH)2 |
207613-14-7 |
99% |
| Y3311304 |
Cl-C6-PEG4-C3-COOH |
2127391-58-4 |
98.0% |
| Y1241482 |
VH032 thiol |
2098836-54-3 |
95% |
| Y3106426 |
Phlogacantholide B |
830347-16-5 |
98.5% |
| Y1250218 |
THP-PEG4-Pyrrolidine(N-Boc)-CH2OH |
2378261-80-2 |
95% |
| Y3292541 |
MP-PEG8-VA-PABC-PBD Dimer |
1595275-62-9 |
98% |
| Y3291853 |
MC-Val-Cit-PAB-vinblastine |
2055896-92-7 |
90% |
| Y3261485 |
Mal-Phe-C4-VC-PAB-MMAE |
2259318-51-7 |
99% |
| Y3185187 |
HO-PEG10-CH2COOH |
2250056-53-0 |
98% |
| Y3288712 |
NAMPT inhibitor-linker 1 |
2241019-57-6 |
98% |
| Y1338704 |
Fmoc-PEA |
329223-23-6 |
98% |
| Y1245793 |
DBCO-PEG2-acid |
2304558-25-4 |
95% |
| Y1250219 |
Lenalidomide-PEG1-azide |
2185795-67-7 |
95% |
| Y3306796 |
DBCO-(PEG2-VC-PAB-MMAE)2 |
2259318-55-1 |
98.73% |
| Y3287785 |
THP-PEG4-Pyrrolidine(N-Me)-CH2OH |
2378261-81-3 |
95% |